William Plovanic
Stock Analyst at Canaccord Genuity
(3.60)
# 835
Out of 5,124 analysts
168
Total ratings
48%
Success rate
6.77%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 → $35 | $21.98 | +59.24% | 7 | Dec 17, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $147 → $148 | $121.65 | +21.66% | 9 | Dec 17, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 → $12 | $6.98 | +71.92% | 5 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $89 → $87 | $85.25 | +2.05% | 30 | Dec 17, 2025 | |
| CBLL CeriBell | Maintains: Buy | $29 → $30 | $21.93 | +36.80% | 5 | Dec 17, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 → $131 | $95.35 | +37.39% | 13 | Dec 17, 2025 | |
| PODD Insulet | Maintains: Buy | $428 → $432 | $284.24 | +51.98% | 7 | Nov 24, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $39 → $40 | $29.15 | +37.22% | 3 | Nov 13, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $45.61 | +11.82% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $7.10 | +54.93% | 9 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $193 → $212 | $177.44 | +19.48% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $99 | $66.37 | +49.16% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $64 | $39.56 | +61.78% | 12 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $12.84 | +40.19% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $1.38 | +407.25% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $87.31 | +3.08% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $89.92 | +12.32% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.44 | +101.61% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $310.91 | -8.66% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $21.04 | +18.82% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $2.21 | +442.99% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $88.14 | -20.58% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $23.09 | +107.88% | 5 | Aug 3, 2023 |
Tandem Diabetes Care
Dec 17, 2025
Maintains: Buy
Price Target: $24 → $35
Current: $21.98
Upside: +59.24%
TransMedics Group
Dec 17, 2025
Maintains: Buy
Price Target: $147 → $148
Current: $121.65
Upside: +21.66%
TriSalus Life Sciences
Dec 17, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $6.98
Upside: +71.92%
Edwards Lifesciences
Dec 17, 2025
Maintains: Hold
Price Target: $89 → $87
Current: $85.25
Upside: +2.05%
CeriBell
Dec 17, 2025
Maintains: Buy
Price Target: $29 → $30
Current: $21.93
Upside: +36.80%
Boston Scientific
Dec 17, 2025
Maintains: Buy
Price Target: $132 → $131
Current: $95.35
Upside: +37.39%
Insulet
Nov 24, 2025
Maintains: Buy
Price Target: $428 → $432
Current: $284.24
Upside: +51.98%
HeartFlow
Nov 13, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $29.15
Upside: +37.22%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $45.61
Upside: +11.82%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $7.10
Upside: +54.93%
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $177.44
Upside: +19.48%
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $66.37
Upside: +49.16%
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $39.56
Upside: +61.78%
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $12.84
Upside: +40.19%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $1.38
Upside: +407.25%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $87.31
Upside: +3.08%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $89.92
Upside: +12.32%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.44
Upside: +101.61%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $310.91
Upside: -8.66%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $21.04
Upside: +18.82%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $2.21
Upside: +442.99%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $88.14
Upside: -20.58%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $23.09
Upside: +107.88%